Miltefosine: issues to be addressed in the future. (Q36495928)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16750231%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

review article

1 reference

title

Miltefosine: issues to be addressed in the future (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16750231%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16750231%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Berman J

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16750231%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Bryceson AD

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16750231%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Croft S

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16750231%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Engel J

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16750231%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Gutteridge W

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16750231%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Karbwang J

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16750231%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Sindermann H

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16750231%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Sundar S

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16750231%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Urbina JA

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16750231%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

publication date

5 June 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16750231%20AND%20SRC:MED&resulttype=core&format=json

Transactions of the Royal Society of Tropical Medicine and Hygiene

29 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16750231%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

100 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16750231%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

S41-4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16750231%20AND%20SRC:MED&resulttype=core&format=json

A policy for leishmaniasis with respect to the prevention and control of drug resistance

29 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.02.009

Dihydro-beta-agarofuran sesquiterpenes: a new class of reversal agents of the multidrug resistance phenotype mediated by P-glycoprotein in the protozoan parasite Leishmania.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.02.009

Functional expression of a multidrug P-glycoprotein transporter of Leishmania

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.02.009

Sensitivities of Leishmania species to hexadecylphosphocholine (miltefosine), ET-18-OCH(3) (edelfosine) and amphotericin B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.02.009

Miltefosine--the long-awaited therapy for visceral leishmaniasis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.02.009

Mechanism of action of anti-proliferative lysophospholipid analogues against the protozoan parasite Trypanosoma cruzi: potentiation of in vitro activity by the sterol biosynthesis inhibitor ketoconazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.02.009

Celastraceae sesquiterpenes as a new class of modulators that bind specifically to human P-glycoprotein and reverse cellular multidrug resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.02.009

Alkyl-lysophospholipid resistance in multidrug-resistant Leishmania tropica and chemosensitization by a novel P-glycoprotein-like transporter modulator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.02.009

Multidrug resistance phenotype mediated by the P-glycoprotein-like transporter in Leishmania: a search for reversal agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.02.009

Leishmania donovani resistance to miltefosine involves a defective inward translocation of the drug

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.02.009

Functional cloning of the miltefosine transporter. A novel P-type phospholipid translocase from Leishmania involved in drug resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.02.009

In vitro and in vivo interactions between miltefosine and other antileishmanial drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.02.009

Characterisation of Leishmania donovani promastigotes resistant to hexadecylphosphocholine (miltefosine).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.02.009

Mefloquine pharmacokinetic-pharmacodynamic models: implications for dosing and resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.02.009

Oral miltefosine for leishmaniasis in immunocompromised patients: compassionate use in 39 patients with HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.02.009

Miltefosine for new world cutaneous leishmaniasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.02.009

Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.02.009

10.1016/J.TRSTMH.2006.02.009

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16750231%20AND%20SRC:MED&resulttype=core&format=json

release_r6jvzsps6bdyvaklcgounrg364

29 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/r6jvzsps6bdyvaklcgounrg364

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16750231%20AND%20SRC:MED&resulttype=core&format=json